Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 1216 AL 1230

Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics

Muir RT, Ismail Z, Black SE, Smith EE.

Alzheimers Dement. 2024 Feb;20(2):1436-1458. doi: 10.1002/alz.13510. Epub 2023 Oct 31.

Innovative SALDI mass spectrometry analysis for Alzheimer's disease synthetic peptides detection

Cournut A, Moustiez P, Coffinier Y, Enjalbal C, Bich C.

Talanta. 2024 Feb 1;268(Pt 2):125357. doi: 10.1016/j.talanta.2023.125357. Epub 2023 Nov 2.

Molecular biomarkers for vascular cognitive impairment and dementia

Hosoki S, Hansra GK, Jayasena T, Poljak A, Mather KA, Catts VS, Rust R, Sagare A, Kovacic JC, Brodtmann A, Wallin A, Zlokovic BV, Ihara M, Sachdev PS.

Nat Rev Neurol. 2023 Dec;19(12):737-753. doi: 10.1038/s41582-023-00884-1. Epub 2023 Nov 13.

Potential Retinal Biomarkers in Alzheimer's Disease

García-Bermúdez MY, Vohra R, Freude K, Wijngaarden PV, Martin K, Thomsen MS, Aldana BI, Kolko M.

Int J Mol Sci. 2023 Oct 31;24(21):15834. doi: 10.3390/ijms242115834.

Alzheimer's Disease Biomarker Detection Using Field Effect Transistor-Based Biosensor

Le PG, Choi SH, Cho S.

Biosensors (Basel). 2023 Nov 17;13(11):987. doi: 10.3390/bios13110987.

Validating blood tests as a possible routine diagnostic assay of Alzheimer's disease

Kodosaki E, Zetterberg H, Heslegrave A.

Expert Rev Mol Diagn. 2023 Jul-Dec;23(12):1153-1165. doi: 10.1080/14737159.2023.2289553. Epub 2023 Dec 15.

Associations between Alzheimer's disease biomarkers and postoperative delirium or cognitive dysfunction: A meta-analysis and trial sequential analysis of prospective clinical trials

Geng J, Zhang Y, Chen H, Shi H, Wu Z, Chen J, Luo F.

Eur J Anaesthesiol. 2024 Mar 1;41(3):234-244. doi: 10.1097/EJA.0000000000001933. Epub 2023 Dec 1.

Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease

Abdelmaksoud NM, Sallam AM, Abulsoud AI, El-Dakroury WA, Abdel Mageed SS, Al-Noshokaty TM, Elrebehy MA, Elshaer SS, Mahmoud NA, Fathi D, Rizk NI, Elballal MS, Mohammed OA, Abdel-Reheim MA, Zaki MB, Saber S, Doghish AS.

Pathol Res Pract. 2024 Jan;253:155007. doi: 10.1016/j.prp.2023.155007. Epub 2023 Dec 4.

Cerebrospinal and Blood Biomarkers in Alzheimer's Disease: Did Mild Cognitive Impairment Definition Affect Their Clinical Usefulness?

Bivona G, Iemmolo M, Ghersi G.

Int J Mol Sci. 2023 Nov 29;24(23):16908. doi: 10.3390/ijms242316908.

Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification

Timsina J, Ali M, Do A, Wang L, Western D, Sung YJ, Cruchaga C.

Neurobiol Dis. 2024 Jan;190:106373. doi: 10.1016/j.nbd.2023.106373. Epub 2023 Dec 9.

Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village

Høilund-Carlsen PF, Alavi A, Barrio JR, Castellani RJ, Costa T, Herrup K, Kepp KP, Neve RL, Perry G, Revheim ME, Robakis NK, Sensi SL, Vissel B.

Ageing Res Rev. 2024 Jan;93:102173. doi: 10.1016/j.arr.2023.102173. Epub 2023 Dec 15.

Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer Disease: Case Series

Sah RP, Vidya CS, Pereira P, Jayaram S, Yadav AK, Sujatha P.

Ann Geriatr Med Res. 2024 Mar;28(1):116-120. doi: 10.4235/agmr.23.0135. Epub 2023 Dec 13.

Is blood pTau a reliable indicator of the CSF status? A narrative review

Antonioni A, Raho EM, Di Lorenzo F.

Neurol Sci. 2024 Jun;45(6):2471-2487. doi: 10.1007/s10072-023-07258-x. Epub 2023 Dec 22.

Recruitment and Screening Methods in Alzheimer's Disease Research: The FIT-AD Trial

Greimel S, Wyman JF, Zhang L, Yu F.

J Gerontol A Biol Sci Med Sci. 2022 Mar 3;77(3):547-553. doi: 10.1093/gerona/glab092.

Presenilin 1 Gene Mutation (M139V) in a German Family with Early-Onset Alzheimer's Disease: A Case Report

Fuentes M, Schipke CG, Freiesleben SD, Klostermann A, Peters O.

Arch Clin Neuropsychol. 2022 Feb 23;37(2):521-530. doi: 10.1093/arclin/acab070.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias